Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Healthcare Triangle meets NASDAQ minimum requirement again through stock issuance
Healthcare Triangle issued 12,546,540 common shares on July 24 to settle the acquisition of Teyame AI and a stock swap with SecureKloud. As a result, total shares outstanding increased to 14,644,322 as of July 28 and the market value of the listed securities rose to about $23.9 million (closing price $1.63). This places the company above the NASDAQ minimum requirement of $5 million effective July 22, although final compliance will be determined by day-to-day price and share-count reviews. » Más en de.investing.com
Healthcare Triangle appoints Sumit Ganguli CEO of AI subsidiary Purpose Health
Healthcare Triangle names Sumit Ganguli chairman and CEO of Purpose Health, its wholly owned subsidiary specializing in AI-enabled technology services for healthcare. Purpose Health will provide AI infrastructure and solutions for providers, payers, life sciences and medtech, focusing on AI-driven IT managed services, strategic joint ventures and multi-year recurring revenue. Ganguli brings more than 30 years of experience in IT and health technology and will drive expansion and partnerships with EHR vendors, cloud partners and AI companies. » Más en de.investing.com
Healthcare Triangle secures $3.6 million through private placement of convertible notes
Healthcare Triangle completed a private placement of senior convertible notes with gross proceeds of about $3.6 million. The notes have an aggregate principal amount of $4.235 million, a 15% discount (Disagio) and mature on December 12, 2026; conversion is possible no earlier than six months after issuance at a price equal to 85% of the volume-weighted average price of the three trading days before the conversion notice. The company, which has a market capitalization of only $4.93 million and reported negative free cash flow of $17.86 million, intends to use the net proceeds to repay existing liabilities, for potential strategic acquisitions and for working capital. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | junio de 2026 | |
|---|---|---|
| Ingresos | 8,05 M | 166,84 % |
| Beneficio bruto | 1,81 M | 332,13 % |
| Beneficio neto | -3,87 M | 233,30 % |
| EBITDA | -3,31 M | 189,32 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 807,62 mil € |
Número de acciones | 1,16 M |
Máximo/mínimo de 52 semanas | 192,69 € - 0,70 € |
| Dividendos | No |
Beta | 1,12 |
Ratio P/E | -0,01 |
Ratio PEG | 0,00 |
Ratio P/B | 0,05 |
Ratio P/S | 0,04 |
Perfil de la empresa
| Nombre | Healthcare Triangle Inc [Common Shares] |
| CEO | Lakshmanan Kannappan |
| Empleados | 41 |
Descubrir activos
Los accionistas de Healthcare Triangle Inc [Common Shares] también invierten en los siguientes activos
![Healthcare Triangle Inc [Common Shares] Logo](https://img.parqet.com/assets/fallback.png)

